Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
57 hedge funds and large institutions have $399M invested in Intercept Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $23K | +$17.8K | +522 | New |
|
52
Ameriprise
Minneapolis,
Minnesota
| $18K | +$13.4K | +391 | New |
|
53
Barclays
London,
United Kingdom
| $15K | +$11.2K | +328 | New |
|
|
SSG
54
Summit Securities Group
New York
| $13K | +$10.2K | +300 | New |
|
55
California Public Employees Retirement System
Sacramento,
California
| $9K | +$6.83K | +200 | New |
|
56
BlackRock
New York
| $7K | +$5.71K | +167 | New |
|
57
Citigroup
New York
| $1K | +$957 | +28 | New |
|
ICPT Hedge Fund Activity: Q2 2013 in Review
57 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q2 2013, worth a combined $399M.
Buyers outnumbered sellers: 57 funds opened new ICPT positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.
- 57 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $399M of Intercept Pharmaceuticals, Inc. stock for Q2 2013.
- 57 funds opened new Intercept Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +57 holders.
Based on aggregated 13F filings for Q2 2013.